LAWLIS V BRYAN

CIK 00012476817 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001247681

Recent Transactions

50 trades

Award
GERON CORP$GERN
Stock Option (right to buy)
2025-05-21+180,000→ 180,000 total
Purchase
GERON CORP$GERN
Common Stock
2025-05-09$1.18/sh+13,300→ 13,300 total
Exercise/Conversion
GERON CORP$GERN
Common Stock
2024-05-15$1.94/sh+35,000→ 35,000 total
Sale
GERON CORP$GERN
Common Stock
2024-05-15$3.75/sh−35,000→ 0 total
Exercise/Conversion
GERON CORP$GERN
Stock Option (right to buy)
2024-05-15−35,000→ 0 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2024-05-09+180,000→ 180,000 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2023-05-31+125,000→ 125,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-05-23+4,190→ 33,140 total
Sale
GERON CORP$GERN
Common Stock
2023-05-11$3.00/sh−35,000→ 0 total
Exercise/Conversion
GERON CORP$GERN
Common Stock
2023-05-11$1.10/sh+35,000→ 35,000 total
Exercise/Conversion
GERON CORP$GERN
Stock Options (right to buy)
2023-05-11−35,000→ 0 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-04-03$97.09/sh−8,500→ 28,950 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to Buy Common Stock)
2023-04-03−8,500→ 0 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-04-03$67.81/sh+8,500→ 37,450 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2022-06-07+43,000→ 43,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-05-24+4,980→ 28,950 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2022-05-10+125,000→ 125,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-04-14$37.46/sh+4,250→ 28,220 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2022-04-14−4,250→ 0 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-04-14$83.66/sh−4,250→ 23,970 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-01-14$87.61/sh−4,250→ 23,970 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2022-01-14$37.46/sh+4,250→ 28,220 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2022-01-14−4,250→ 4,250 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-05-25+5,120→ 23,970 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2021-05-11+83,000→ 83,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-04-15$26.49/sh+7,500→ 26,350 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-04-15−7,500→ 0 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-04-15$76.90/sh−7,500→ 18,850 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-02-16$87.41/sh−7,500→ 18,850 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-02-16−7,500→ 7,500 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-02-16$26.49/sh+7,500→ 26,350 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-11+20,000→ 20,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2020-06-08+28,100→ 28,100 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-06-05$107.46/sh−4,430→ 18,850 total
Award
GERON CORP$GERN
Stock Option (right to buy)
2020-06-05+83,000→ 83,000 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-05-27+4,300→ 23,280 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2020-03-17−3,750→ 0 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-03-17$21.51/sh+3,750→ 22,730 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-03-17$75.39/sh−3,750→ 18,980 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2020-03-16$76.52/sh−4,610→ 18,980 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-10+20,000→ 20,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-12-17$83.36/sh−3,750→ 23,590 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-12-17$21.51/sh+3,750→ 27,340 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2019-12-17−3,750→ 3,750 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-09-17$21.51/sh+3,750→ 27,340 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2019-09-17−3,750→ 7,500 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-09-17$74.47/sh−3,750→ 23,590 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2019-06-17−3,750→ 11,250 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-06-17$21.51/sh+3,750→ 27,340 total

LAWLIS V BRYAN

Recent Transactions

Companies

Recent Filings

Address